Plasma thrombomodulin levels in women with systemic lupus erythematosus

C. D. Hsu, D. W. Chan, B. Iriye, T. R.B. Johnson, S. F. Hong, M. Petri

Research output: Contribution to journalArticlepeer-review

Abstract

Thrombomodulin (TM), an endothelial cell membrane glycoprotein, is released into blood as a soluble TM antigen after inflammation or injury to endothelium. Systemic lupus erythematosus (SLE) is characterized by multisystem inflammation of vascular endothelium. The objective of this study is to determine the circulating TM levels in pregnant and nonpregnant SLE women and the correlation of plasma TM levels with variables used to assess SLE activity. We found that there were no significant differences in plasma TM levels among pregnant SLE, nonpregnant SLE, and normal pregnant patients. However, significantly higher plasma TM levels were found in some SLE women with active disease or preeclampsia.

Original languageEnglish (US)
Pages (from-to)27-29
Number of pages3
JournalAmerican journal of perinatology
Volume12
Issue number1
DOIs
StatePublished - Jan 1 1995

Keywords

  • Thrombomodulin
  • endothelial damage
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Plasma thrombomodulin levels in women with systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this